HF  Baillie Gifford

https://www.bailliegifford.com/





     Office Locations:

780 Third Avenue, 43rd Floor
New York, NY 10017
Phone: 212-319-4633
Fax: 212-319-4639

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early


 

Industries:

  • Consumer Products & Services
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet

  •  

    Description:

    Baillie Gifford was established as an investment management partnership over 110 years ago. manages and advises US$ 445.3bn in specialist equity, fixed income and multi-asset portfolios for a global client base. The firm's geographical exposure also encompasses professional investor clients in Australia, Singapore, Hong Kong, China, Thailand, Korea, the Middle East and South Africa. Baillie Gifford today is wholly owned by its 46 partners, all of whom work within the firm. Baillie Gifford Schiehallion Fund (MNTN) is a closed-end investment company dedicated to the unlisted 'unicorns' that its flagship Scottish Mortgage Trust (SMT) has successfully pioneered.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Mark Urquhart Senior Investment Manager
    Peter Singlehurst
    Spencer Adair

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/02/2024


      Tenstorrent


      CA


      $693,000,000


      Series D


      11/21/2024


      Enveda Biosciences


      CO


      $130,000,000


      Series C


      07/31/2024


      Cosm


      CA


      $250,000,000


      


     

    Portfolio companies include:

     

    Recent News: